Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Certain hormone treatments can improve acne and related conditions in women.

NSAIDs may not affect soft tissue healing but should be used carefully for bone fractures and more research is needed to understand sex differences in response.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

3D-printed mesoporous scaffolds show promise for personalized drug delivery with controlled release.

Safflower has been used in traditional medicine for centuries and shows promise in treating heart, brain, and inflammatory conditions, but more research is needed to ensure its safety.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Ozone therapy might improve cancer treatment and reduce its side effects.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.